{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:53:53Z","timestamp":1765234433105},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Government of Australia"},{"name":"Arthritis Research UK Fellowship","award":["20305"],"award-info":[{"award-number":["20305"]}]},{"DOI":"10.13039\/100008717","name":"Sylvia and Charles Viertel Charitable Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008717","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.037","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:22:52Z","timestamp":1419294172000},"page":"321-328","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis"],"prefix":"10.1016","volume":"238","author":[{"given":"Gareth W.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Bozinovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meri","family":"Najdovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2014.12.037_bib1","article-title":"Cardiovascular disease risk factors: epidemiology and risk assessment","volume":"105","author":"Dahl\u00f6f","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib2","first-page":"343","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib3","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11886-011-0220-3","article-title":"The role of triglycerides in atherosclerosis","volume":"13","author":"Talayero","year":"2011","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","article-title":"Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities","volume":"167","author":"Mahdy Ali","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1160\/TH09-05-0297","article-title":"How much is too much? Interleukin-6 and its signalling in atherosclerosis","volume":"102","author":"Schuett","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.180.4.1243","article-title":"Defective inflammatory response in interleukin 6-deficient mice","volume":"180","author":"Fattori","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib9","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1084\/jem.20070120","article-title":"Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man","volume":"204","author":"Luchtefeld","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2004.06.018","article-title":"IL-6 and the acute phase response in murine atherosclerosis","volume":"177","author":"Song","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.atherosclerosis.2007.02.023","article-title":"Atheroprotective role of interleukin-6 in diet- and\/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model","volume":"197","author":"Madan","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib13","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib15","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1073\/pnas.100135197","article-title":"Suppressor of cytokine signaling-3 preferentially binds to the SHP-2 binding site on the shared cytokine receptor subunit gp130","volume":"97","author":"Nicholson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2010.07.029","article-title":"AAV\/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol","volume":"213","author":"Khan","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/ATVBAHA.108.173781","article-title":"Suppressors of cytokine signaling modulate JAK\/STAT-mediated cell responses during atherosclerosis","volume":"29","author":"Ortiz-Mu\u00f1oz","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib18","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib19","doi-asserted-by":"crossref","first-page":"31460","DOI":"10.1074\/jbc.M704267200","article-title":"Role of the Jak\/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in\u00a0vitro and in atherosclerosis in\u00a0vivo","volume":"282","author":"Gharavi","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nm763","article-title":"Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice","volume":"8","author":"Tebbutt","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nm1282","article-title":"Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling","volume":"11","author":"Jenkins","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2012.08.010","article-title":"STAT3-Driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation","volume":"22","author":"Tye","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/icb.2011.56","article-title":"LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling","volume":"90","author":"Greenhill","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib25","doi-asserted-by":"crossref","first-page":"e29371","DOI":"10.1371\/journal.pone.0029371","article-title":"Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation","volume":"7","author":"Kyaw","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","article-title":"Cardiovascular disease risk reduction by raising HDL cholesterol\u2013current therapies and future opportunities","volume":"167","author":"Mahdy Ali","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib27","doi-asserted-by":"crossref","first-page":"F679","DOI":"10.1152\/ajprenal.90680.2008","article-title":"Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice","volume":"297","author":"Tomiyama-Hanayama","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib28","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2004-09-3751","article-title":"The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis","volume":"105","author":"Jenkins","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/ATVBAHA.113.302247","article-title":"Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice","volume":"34","author":"De Beer","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2010.10.009","article-title":"Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemia","volume":"214","author":"Luo","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib33","first-page":"767","article-title":"mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice","volume":"123","author":"Thiem","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cmet.2007.10.007","article-title":"Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease","volume":"6","author":"Fern\u00e1ndez-Hernando","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2014.12.037_bib35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cmet.2012.04.020","article-title":"Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice","volume":"15","author":"Ding","year":"2012","journal-title":"Cell Metab."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T14:50:49Z","timestamp":1566139849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014016591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0021915014016591"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.037","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}